
    
      Randomized, double blind, placebo controlled study. The study will include 108 patients with
      cutenous leishmaniasis of Leishmania species major and tropica, confired by Polymerase Chain
      Reaction of a sample from a lesion.

      Cure rate will be compared between patients treated with Amphotericin-B 0.4% Liposomal Gel
      and patients treated with placebo gel preparation.
    
  